The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
NRG Oncology NRG-GI007 trial-in-progress: Phase I study of OBP-301 (Telomelysin) and definitive chemoradiation (CRT) for patients with locally advanced esophageal and gastroesophageal adenocarcinoma who are not candidates for surgery.
 
Geoffrey Yuyat Ku
Consulting or Advisory Role - Lilly; Merck Sharp & Dohme; Pieris Pharmaceuticals
Research Funding - Arog (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); MedImmune (Inst); Merck (Inst); Oncolys BioPharma (Inst); Pieris Pharmaceuticals (Inst); Zymeworks (Inst)
Travel, Accommodations, Expenses - Aduro Biotech; AstraZeneca/MedImmune; Bristol-Myers Squibb; Merck Sharp & Dohme; Pieris Pharmaceuticals
 
Kathryn A. Winter
No Relationships to Disclose
 
Terence Marques Williams
No Relationships to Disclose
 
Prasad S. Adusumilli
Consulting or Advisory Role - Atara Biotherapeutics; Bayer; Carisma Therapeutics; ImmPACT-Bio; Imugene; Takeda
Research Funding - ACEA Biosciences; Atara Biotherapeutics; OSE Immunotherapeutics
Patents, Royalties, Other Intellectual Property - Mesothelin CAR PD-1 DNR
Travel, Accommodations, Expenses - OSE Immunotherapeutics
 
Makoto Nishimura
Consulting or Advisory Role - Boston Scientific; Lumendi; Olympus
 
Adam Yock
No Relationships to Disclose
 
David H. Ilson
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Lilly/ImClone; Merck; Pieris Pharmaceuticals; Roche/Genentech; Taiho Pharmaceutical
 
Theodore S. Hong
Consulting or Advisory Role - Merck; Novocure; Synthetic Biologics
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Intrinsic LifeSciences (Inst); Ipsen (Inst); Novartis (Inst); Taiho Pharmaceutical (Inst); Tesaro (Inst)